Lipoprotein-associated phospholipase A2 activity is a marker of risk but not a useful target for treatment in patients with stable coronary heart disease (pealkiri)

teaviku laadid

Toon andmeid..
Toon andmeid..
Toon andmeid..
Toon andmeid..
Toon andmeid..
Toon andmeid..
Kirjeid leitud 1, kuvan 1 - 1